IRB Review Services for Phase I Research

Our dedicated team and processes are built to support your Phase I research needs.

Rely on customized IRB capabilities to ensure appropriate, efficient reviews:

• Responsive, multi-functional team to ensure service excellence and eliminate delays
• Real-time access to review status information and approval documents
• Daily specialized IRB panels to review Phase I research and changes to previously approved research
• IRB review and approval issued prior to FDA 30-day investigational new drug (IND) wait period

To learn more, fill out the form to download the info sheet.